Academician profile · DOKTOR ÖĞRETİM ÜYESİ
SERCAN ÖN
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
- TIP FAKÜLTESİ
- DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
Scopus (SJR)
Q1
5
Q2
1
Q3
3
Q4
4
WoS (JCR)
Q1
3
Q2
3
Q3
2
Q4
4
TR Index
7
articles
Articles
- 2026 Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group
- 2025 Real-World Pathologic Complete Response Rates with Neoadjuvant Pembrolizumab in Stage II–III Triple-Negative Breast Cancer: Impact of Ki-67 Proliferation Index
- 2025 Efficacy of pembrolizumab in patients with chemotherapy-resistant gestational trophoblastic neoplasia, a case report
- 2025 Long-term Outcomes in Stage I Seminoma Patients: A Single-center Retrospective Study
- 2025 Tıbbi Onkoloji Polikliniğine Başvuran Yeni Tanı Kanser Hastalarında, Hastalıkları Hakkındaki Bilgi ve Farkındalık Düzeyi
- 2025 Body Mass Index as an Independent Prognostic Factor in Second-Line Nivolumab Therapy for Metastatic Clear Cell Renal Cell Carcinoma
- 2024 Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)
- 2024 Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study
- 2024 Radiotherapy can be a Cofactor in the Development and Severity of Lapatinib-Capecitabine-Related Skin Rash
- 2023 Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
- 2023 PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study
- 2023 Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
- 2022 Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study
- 2022 Immunotherapy-induced granulomatous reaction in patients with melanoma
- 2022 Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group
- 2022 Evaluation of treatment efficacy of tyrosine kinase inhibitors in rare single EGFR Exon 21 L861Q mutation: Single center experience